Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Microsoft
MSFT
|
+$7.54B |
| 2 |
Apple
AAPL
|
+$5.11B |
| 3 |
Amazon
AMZN
|
+$2.93B |
| 4 |
UnitedHealth
UNH
|
+$2.83B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$2.75B |
Top Sells
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$330M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Twilio
TWLO
|
+$309M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$156M |
| 5 |
AVLR
Avalara, Inc.
AVLR
|
+$154M |
Sector Composition
| 1 | Technology | 29.71% |
| 2 | Healthcare | 21.23% |
| 3 | Financials | 11.2% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRP.U
726
Granite Real Estate Investment Trust
GRP.U
$3.43B
| $15.6M | 0.01% |
322,176
+185,030
| +135% | +$8.97M |
|
727
Emerson Electric
EMR
$75.2B
| $15.6M | 0.01% |
213,296
+90,971
| +74% | +$6.66M |
|
728
FS KKR Capital
FSK
$4.98B
| $15.5M | 0.01% |
916,268
+724,854
| +379% | +$12.3M |
|
729
Nuvalent
NUVL
$5.66B
| $15.5M | 0.01% |
797,312
-449,853
| -36% | -$8.74M |
|
|
TCVA
730
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
| $15.3M | 0.01% |
+1,560,516
| New | +$15.3M |
|
|
CCVI
731
DELISTED
Churchill Capital Corp VI
CCVI
| $15.2M | 0.01% |
+1,548,026
| New | +$15.2M |
|
732
Global E Online
GLBE
$6.22B
| $15.2M | 0.01% |
568,866
-1,054,563
| -65% | -$28.2M |
|
733
Manulife Financial
MFC
$52.4B
| $15.2M | 0.01% |
967,308
-311,066
| -24% | -$4.89M |
|
734
Coherent
COHR
$16.1B
| $15M | 0.01% |
431,146
+282,989
| +191% | +$9.86M |
|
|
DEN
735
DELISTED
Denbury Inc.
DEN
| $15M | 0.01% |
174,098
-398,016
| -70% | -$34.3M |
|
|
BDXB
736
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $15M | 0.01% |
320,200
+161,100
| +101% | +$7.53M |
|
737
Vanguard Small-Cap ETF
VB
$66.7B
| $14.9M | 0.01% |
87,304
+83,656
| +2,293% | +$14.3M |
|
738
TC Energy
TRP
$54B
| $14.9M | 0.01% |
369,028
+148,456
| +67% | +$6M |
|
739
Ball Corp
BALL
$13.6B
| $14.9M | 0.01% |
308,520
+170,228
| +123% | +$8.23M |
|
740
Keurig Dr Pepper
KDP
$37.3B
| $14.9M | 0.01% |
415,562
+153,645
| +59% | +$5.5M |
|
741
Paychex
PAYX
$47.9B
| $14.8M | 0.01% |
132,206
+90,388
| +216% | +$10.1M |
|
742
Omega Healthcare
OHI
$12.6B
| $14.8M | 0.01% |
500,922
+379,257
| +312% | +$11.2M |
|
743
Annaly Capital Management
NLY
$14.2B
| $14.7M | 0.01% |
858,526
+643,008
| +298% | +$11M |
|
744
Starwood Property Trust
STWD
$7.6B
| $14.7M | 0.01% |
805,148
+479,342
| +147% | +$8.73M |
|
|
CPUH
745
DELISTED
Compute Health Acquisition Corp.
CPUH
| $14.7M | 0.01% |
1,486,544
+1,176,908
| +380% | +$11.6M |
|
746
B2Gold
BTG
$5.74B
| $14.6M | 0.01% |
4,517,628
+1,248,310
| +38% | +$4.03M |
|
747
Fortinet
FTNT
$60.9B
| $14.6M | 0.01% |
296,326
+203,271
| +218% | +$9.98M |
|
748
Bank of New York Mellon
BK
$73.3B
| $14.5M | 0.01% |
375,394
+288,696
| +333% | +$11.1M |
|
749
PNC Financial Services
PNC
$79.5B
| $14.4M | 0.01% |
96,470
+45,402
| +89% | +$6.79M |
|
750
C4 Therapeutics
CCCC
$188M
| $14.4M | 0.01% |
1,637,494
+787,894
| +93% | +$6.91M |
|